The late recurrences in HR+HER2- disease seemed to be approximately ascribed to distant recurrences, which might possibly give further support to a previously unknown dormancy state that, at the primary tumor surgical removal, results in evolving chemo-sensitive metastatic processes, and, moreover, of a later chemo-refractory dormancy state (33). This evidence concerns the gene ERBB2 and neoplasm.